v3.25.1
Condensed Consolidated Statement of Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Shares
Treasury Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2023   26,495,250        
Beginning balance at Dec. 31, 2023 $ 18,395 $ 315,634 $ (2,854) $ 63,748 $ (360,096) $ 1,963
Beginning balance, treasury stock (in shares) at Dec. 31, 2023     (408,070)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares, net of underwriters’ discount and issuance costs (in shares)   1,101,565        
Issuance of common shares, net of underwriters’ discount and issuance costs 49,736 $ 49,736        
Issuance of common shares in lieu of cash compensation (in shares)   2,158        
Issuance of common shares in lieu of cash compensation 110 $ 110        
Stock option exercises (in shares)   53,400        
Stock option exercises 1,426 $ 1,426        
Warrant exercises (in shares)   223,019        
Warrant exercises 0 $ 223   (223)    
Share-based compensation (in shares)   11,979        
Share-based compensation 3,444 $ 12   3,432    
Shares withheld to cover income tax obligation upon vesting of restricted stock (in shares)   (2,622)        
Shares withheld to cover income tax obligation upon vesting of restricted stock (119) $ (3)   (116)    
Foreign currency translation loss (gain) 121         121
Net loss (16,202)       (16,202)  
Ending balance (in shares) at Mar. 31, 2024   27,884,749        
Ending balance at Mar. 31, 2024 $ 56,911 $ 367,138 $ (2,854) 66,841 (376,298) 2,084
Ending balance, treasury stock (in shares) at Mar. 31, 2024     (408,070)      
Beginning balance (in shares) at Dec. 31, 2024 28,787,369 29,195,439        
Beginning balance at Dec. 31, 2024 $ 53,095 $ 420,364 $ (2,854) 76,992 (444,692) 3,285
Beginning balance, treasury stock (in shares) at Dec. 31, 2024 (408,070)   (408,070)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares in lieu of cash compensation (in shares)   90,153        
Issuance of common shares in lieu of cash compensation $ 4,062 $ 4,062        
Stock option exercises (in shares) 4,260 4,260        
Stock option exercises $ 79 $ 79        
Share-based compensation (in shares)   33,530        
Share-based compensation 2,434 $ 34   2,400    
Shares withheld to cover income tax obligation upon vesting of restricted stock (in shares)   (6,975)        
Shares withheld to cover income tax obligation upon vesting of restricted stock (282) $ (7)   (275)    
Foreign currency translation loss (gain) (128)         (128)
Net loss $ (20,710)       (20,710)  
Ending balance (in shares) at Mar. 31, 2025 28,908,337 29,316,407        
Ending balance at Mar. 31, 2025 $ 38,550 $ 424,532 $ (2,854) $ 79,117 $ (465,402) $ 3,157
Ending balance, treasury stock (in shares) at Mar. 31, 2025 (408,070)   (408,070)